News24.com | India approves human trials for second Covid-19 vaccine candidate
Zydus has received approval from Indian regulators to begin human studies for its Covid-19 vaccine contender, the drugmaker has announced.
Full Article
News24.com | India approves human trials for second Covid-19 vaccine candidate
News24
0 shares
1 views
You might like
Related news coverage
US sinks another $2.1 billion into a potential vaccine
SeattlePI.com
LONDON (AP) — Pharma giants GlaxoSmithKline and Sanofi Pasteur have announced they will supply 100 million doses of an..
-
Panel recommends permission to Serum Institute for phase 2, 3 human clinical trials of Oxford vaccine candidate
IndiaTimes
-
Nod to Serum Institute for trials of Oxford vaccine
IndiaTimes
-
Rohtak man, 54, joins human trial of Covaxin after son
IndiaTimes
-
Union Health Minister: Herd immunity no option given the country's size
Mid-Day
Advertisement
More coverage
Vaccine Candidate Delivers Protection In A Single Shot (In Monkeys)
NPR
Studies COVID-19 vaccine candidates in monkeys show promise of an effective vaccine, but it will large scale human trials to know..
-
COVID-19 herd immunity not an option for population size like India: Health ministry
Mid-Day
-
Johnson & Johnson's Covid-19 Vaccine Protects Monkeys, Study Finds
NYTimes.com
-
DCGI asks Serum Institute to revise protocol for phase 2, 3 trials of Oxford COVID-19 vaccine
IndiaTimes
-
Oxford Covid-19 vaccine candidate trials in India: Pune firm asked to revise proposal
Indian Express